Risk factors for vasoplegia after coronary artery bypass and valve surgery

Vasoplegia denotes a state of low tissue perfusion characterized by hypotension, tachycardia, and low systemic vascular resistance. This state results in increased mortality and morbidity following cardiac surgery. A better understanding of the associated risk factors will guide the surgical team in patient management. The aim of this study is to determine which risk factors are involved in its emergence.

[1]  C. Jabaley,et al.  Vasoplegia after cardiopulmonary bypass: A narrative review of pathophysiology and emerging targeted therapies , 2020, SAGE open medicine.

[2]  R. Cal,et al.  Risk factors for vasoplegia after cardiac surgery: a meta-analysis. , 2019, Interactive cardiovascular and thoracic surgery.

[3]  S. Shaefi,et al.  Off-Pump Versus On-Pump Coronary Artery Bypass Grafting-A Systematic Review and Analysis of Clinical Outcomes. , 2019, Journal of cardiothoracic and vascular anesthesia.

[4]  Lynn M. Wilson,et al.  Risk assessment and outcomes of vasoplegia after cardiac surgery , 2017, General Thoracic and Cardiovascular Surgery.

[5]  Wei Wei,et al.  Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis , 2017, World journal of gastroenterology.

[6]  M. Kirov,et al.  Low-Cardiac-Output Syndrome After Cardiac Surgery. , 2017, Journal of cardiothoracic and vascular anesthesia.

[7]  M. Schalij,et al.  Incidence and predictors of vasoplegia after heart failure surgery , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[8]  M. Hall,et al.  Cardiopulmonary Bypass-Induced Inflammatory Response: Pathophysiology and Treatment , 2016, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[9]  G. Angelini,et al.  Cardiopulmonary Bypass and Oxidative Stress , 2015, Oxidative medicine and cellular longevity.

[10]  K. Nugent,et al.  Cardiac Vasoplegia Syndrome: Pathophysiology, Risk Factors and Treatment , 2015, The American journal of the medical sciences.

[11]  J. Lopez-Delgado,et al.  The inflammatory response in cardiac surgery: an overview of the pathophysiology and clinical implications. , 2014, Inflammation & allergy drug targets.

[12]  J. O. Pestana,et al.  Cardiopulmonary bypass increases the risk of vasoplegic syndrome after coronary artery bypass grafting in patients with dialysis-dependent chronic renal failure , 2014, Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular.

[13]  T. Coffman,et al.  Classical Renin-Angiotensin system in kidney physiology. , 2014, Comprehensive Physiology.

[14]  Meng Xu,et al.  Transfusion increases the risk for vasoplegia after cardiac operations. , 2011, The Annals of thoracic surgery.

[15]  G. Fischer,et al.  Vasoplegia during cardiac surgery: current concepts and management. , 2010, Seminars in Thoracic and Cardiovascular Surgery.

[16]  Gregory W Fischer,et al.  Early On–Cardiopulmonary Bypass Hypotension and Other Factors Associated With Vasoplegic Syndrome , 2009, Circulation.

[17]  P. Corso,et al.  Is incidence of postoperative vasoplegic syndrome different between off-pump and on-pump coronary artery bypass grafting surgery? , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  M. Westphal,et al.  Role of vasopressinergic V1 receptor agonists in the treatment of perioperative catecholamine-refractory arterial hypotension. , 2008, Best practice & research. Clinical anaesthesiology.

[19]  M. Haubitz,et al.  Direct evidence of endothelial injury during cardiopulmonary bypass by demonstration of circulating endothelial cells , 2006, Perfusion.

[20]  Xiang Xiaoyong,et al.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment , 2005 .

[21]  G. Murphy,et al.  Side Effects of Cardiopulmonary Bypass: , 2004, Journal of cardiac surgery.

[22]  G. Theilmeier,et al.  Inflammatory response to cardiac surgery: cardiopulmonary bypass versus non-cardiopulmonary bypass surgery. , 2004, Best practice & research. Clinical anaesthesiology.

[23]  T. Mihaljevic,et al.  Risk factors and outcomes for 'vasoplegia syndrome' following cardiac transplantation. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[24]  T. Yau,et al.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[25]  P. Biglioli,et al.  Increase of bradykinin in plasma of patients undergoing cardiopulmonary bypass: the importance of lung exclusion. , 2001, Chest.

[26]  D. Landry,et al.  The pathogenesis of vasodilatory shock. , 2001, The New England journal of medicine.

[27]  D. Loisance,et al.  Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. , 2001, The Annals of thoracic surgery.

[28]  M. Oz,et al.  Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. , 1998, The Journal of thoracic and cardiovascular surgery.

[29]  E. Buffolo,et al.  Vasoplegic syndrome after open heart surgery. , 1998, The Journal of cardiovascular surgery.

[30]  E. Buffolo,et al.  Vasoplegic syndrome: a new dilemma. , 1994, The Journal of thoracic and cardiovascular surgery.